Danny H Sugimoto,Steven G Chrysant,Michael Melino et al.
Danny H Sugimoto et al.
Background: Elevated systolic blood pressure is more difficult to control than elevated diastolic blood pressure. The objective of this prespecified analysis of the Triple Therapy with Olmesartan Medoxomil, Amlodipine, an...
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS) [0.03%]
评价胃肠输药系统(GITS)剂型及其作为降压药物递送系统的有效性(侧重硝苯地平缓释片)
Peter A Meredith,Henry L Elliott
Peter A Meredith
Hypertension treatment guidelines do not discriminate within drug classes and, furthermore, do not consider whether or not all of the formulations of any given drug licensed for once-daily administration can be considered to be therapeutica...
Current perspectives on combination therapy in the management of hypertension [0.03%]
高血压治疗中联合用药的现状及思考
Samir G Mallat,Houssam S Itani,Bassem Y Tanios
Samir G Mallat
Hypertension (HTN) is a worldwide health problem and a major preventable risk factor for cardiovascular (CV) events. Achieving an optimal blood pressure (BP) target for patients with HTN will often require more than one BP-lowering drug. Co...
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination [0.03%]
高血压的联合治疗优化：阿利吉仑、氨氯地平和氢氯噻嗪复方制剂的作用
Michael B Hovater,Edgar A Jaimes
Michael B Hovater
High blood pressure is the leading risk factor for death and disability worldwide, and the prevalence is increasing. Effective treatment decreases the risk of adverse events in proportion to blood pressure reduction. Combination antihyperte...
Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy [0.03%]
长效硝苯地平治疗中东和摩洛哥高血压患者的疗效及单药或联合疗法的耐受性观察
Raafat Al Ghoneim,Abdalla Kamal Omar,Vj Sebastian et al.
Raafat Al Ghoneim et al.
Background: The Middle Eastern and North African region of developing countries is associated with poor rates of blood pressure (BP) control and antihypertensive prescribing patterns. This post hoc analysis of data from a...
Judy Wm Cheng
Judy Wm Cheng
Background: Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) fo...
Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness [0.03%]
心血管指数(CAVI)与动脉僵硬度的关系
Cheuk-Kwan Sun
Cheuk-Kwan Sun
Arterial stiffness has been identified as an independent predictor of prognostic outcomes for patients with cardiovascular disease. Although measurement of pulse wave velocity has been a widely accepted noninvasive approach to the assessmen...
Miao Hu,Brian Tomlinson
Miao Hu
Rosuvastatin is one of the most potent statins available for reducing circulating low-density lipoprotein cholesterol (LDL-C) levels, which enables more high-risk patients to achieve their lipid goals. Its favorable balance of effects on at...
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial [0.03%]
不同年龄、性别、种族以及高血压严重程度的人群服用替米沙坦氢氯噻嗪单片固定剂量80毫克/25毫克的降压疗效和耐受性：一项随机试验的事后分析
Dingliang Zhu,Harold Bays,Pingjin Gao et al.
Dingliang Zhu et al.
Background: The purpose of this work was to describe the efficacy and safety of a telmisartan 80 mg + hydrochlorothiazide 25 mg (T80/H25) single-pill combination therapy in patients with moderate-severe hypertension (mean...
Jean-Philippe Baguet
Jean-Philippe Baguet
Hypertension is an important risk factor for the development of cardiovascular disease, and is a major cause of morbidity and mortality worldwide. Traditionally, hypertension diagnosis and treatment and clinical evaluations of antihypertens...